BIOMAT Database Logo BIOMAT Database Logo

[Human tuberculosis produced by streptomycin resistant bacteria]. 1952

A CETRANGOLO, and R CETRANGOLO

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

A CETRANGOLO, and R CETRANGOLO
[Effect of streptomycin on the fever in human tuberculosis with resistant bacteria and on experimentally produced fever in animal].
January 1953, Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung,
A CETRANGOLO, and R CETRANGOLO
[Tuberculosis reinfection by streptomycin-resistant bacilli].
January 1951, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
A CETRANGOLO, and R CETRANGOLO
[Determination of streptomycin concentration by acid-resistant bacteria].
August 1950, Klinicheskaia meditsina,
A CETRANGOLO, and R CETRANGOLO
Adsorption of streptomycin by susceptible and resistant bacteria.
May 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A CETRANGOLO, and R CETRANGOLO
Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms.
March 1949, Science (New York, N.Y.),
A CETRANGOLO, and R CETRANGOLO
[Conjugal tuberculosis superinfection by streptomycin resistant Koch bacillus].
June 1950, Lyon medical,
A CETRANGOLO, and R CETRANGOLO
[Evolution of streptomycin-resistant tuberculosis].
August 1952, Lyon medical,
A CETRANGOLO, and R CETRANGOLO
[Can intraleucocytic bacteria become streptomycin resistant?].
February 1952, Comptes rendus des seances de la Societe de biologie et de ses filiales,
A CETRANGOLO, and R CETRANGOLO
Streptomycin-sensitive, -dependent, and -resistant Bacteria.
February 1948, Science (New York, N.Y.),
A CETRANGOLO, and R CETRANGOLO
[Action of kanamycin alone and associated with isoniazid in experimental tuberculosis induced by streptomycin-resistant bacteria].
February 1960, Giornale di clinica medica,
Copied contents to your clipboard!